April 21, 2022 - April 25, 2022

Global Longlife Hospital IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Global Longlife Hospital IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Global Longlife Hospital IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Global Longlife Hospital IPO Review by Dilip Davda (Avoid)

[Dilip Davda] The company that originally filed its offer documents for NSE SME listing is now settling for BSE SME listing and raises concern over the IPO approval process. Boosted profits for the current fiscal first nine months’ performance raises eyebrows and suspension on window dressing for such fancy valuation and lure investors. Despite super earnings for 9M-FY22, its IPO pricing is at a higher P/E of 38. There is no harm in skipping this pricy bet. Read detail review...

Global Longlife Hospital IPO Review by Members

Global Longlife Hospital IPO Reviews, analysis and views by popular members. Read Global Longlife Hospital and Research Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Global Longlife Hospital IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	1	0	2	6
%	11.11	0.00	22.22	66.67

Member	Review
Visamp	Avoid Avoid April 23, 2022 2:49:04 PM
SaRang 사랑 IPO Guru (1300+ Posts, 2000+ Likes)	Neutral As so many IPOs are open for subscription so I am not interested in this IPO. April 24, 2022 9:20:52 AM
Sanvi	Avoid High valuation and demanding high public money to run the biz April 23, 2022 10:45:05 AM
RJ Rocks IPO Mentor (500+ Posts, 200+ Likes)	Neutral Over priced April 24, 2022 6:06:32 PM
Ravu (700+ Posts, 400+ Likes)	Avoid Exorbitant price , risky bet April 24, 2022 8:58:42 PM
Learner SK Top Contributor (1000+ Posts, 200+ Likes)	Avoid First issue of LM suffered 50% loss on listing day and this is probably the second issue. LM seems lack of experience on valuation. April 24, 2022 7:22:42 AM
LallanP	Avoid -Only one centre. April 23, 2022 5:30:11 PM
IPO Gyaaan (200+ Posts)	Apply for Listing Gain at Cut-off Price Good subscription number April 25, 2022 1:57:21 PM
Asoke sarkar IPO Mentor (700+ Posts, 800+ Likes)	Avoid Nothing in it. Exorbitant price. April 23, 2022 12:21:49 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.